Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Pediatric Blood & Ca...arrow_drop_down
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao
Pediatric Blood & Cancer
Article . 2025 . Peer-reviewed
License: Wiley Online Library User Agreement
Data sources: Crossref
versions View all 2 versions
addClaim

CD123‐Targeted Therapy to Achieve Negative Measurable Residual Disease in Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm Prior to Transplantation

Authors: Flavia Gava; Luiz Fernando Bazzo Catto; Marilia Bazzo Catto; Ana Luiza Morais; Maristella Bergamo Francisco dos Reis; Thiago Eleuterio Gonçalves; Luiz Guilherme Darrigo Jr; +2 Authors

CD123‐Targeted Therapy to Achieve Negative Measurable Residual Disease in Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm Prior to Transplantation

Related Organizations
Powered by OpenAIRE graph
Found an issue? Give us feedback